Back

Why do we still not have cardioprotective drugs on the market?

24 May 2016 (09:37 - 10:00)
Organised by:
Congress Presentation Part of: Myocardial protection and regeneration: can we change the balance in heart failure? Myocarditis HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Peter Ferdinandy

Semmelweis University, Budapest (Hungary)

3 More presentations in this session

Presentation thumbnail
What is wrong with cardiac conditioning in clinical practice?
Professor E. Iliodromitis (Athens, GR)
Slides Video
Presentation thumbnail
Lessons learned from recent trials.
Professor D. Yellon (London, GB)
Slides Video
Presentation thumbnail
Determinants of heart failure after myocardial infarction.
Professor M. Ovize (Lyon Cedex 03, FR)
Slides Video

Access the full session

Session thumbnail
Myocardial protection and regeneration: can we change the balance in heart failure?

The Event

Event poster

HEART FAILURE 2016

24 May 2016 09:37 CET
You may be interested in
thumbnail
Congress Presentation
A novel drug candidate targeting the adrenergic regulation of the SERCA2 complex protect the heart from myocardial infarct injury
21 May 2023
thumbnail
Congress Session
Emerging insights in cardio-oncology: biomarkers, cardiotoxicity, and protective therapies
20 May 2025
thumbnail
Congress Presentation
3 September 2019
thumbnail
Congress Presentation
Different cardioprotection protocols for elective heart surgery surgery in patients with advanced left ventricular failure- a comparison of del Nido and cold blood cardioplegia.
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources